Evolocumab Biosimilar, Human PCSK9 Antibody | C105P
Evolocumab Biosimilar, Human PCSK9 Monoclonal Antibody. The research grade evolocumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available.
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg | C040P.05
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Durvalumab Biosimilar, Anti-human PD-L1 Antibody | C025P
Durvalumab Biosimilar, PD-L1 Monoclonal Antibody. The research grade Durvalumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Omalizumab Biosimilar, Anti-human IgE Antibody | C020P
Omalizumab Biosimilar, Human IgE Monoclonal Antibody. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human...
Palivizumab Biosimilar, Anti-RSV Antibody | C021P
Palivizumab Biosimilar, RSV Monoclonal Antibody. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...
Panitumumab Biosimilar, Anti-human EGFR Antibody | C012P
Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 Monoclonal Antibody. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant...
Durvalumab Biosimilar, Endotoxin 0.05 EU/mg | C025P.05
Durvalumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Durvalumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Omalizumab Biosimilar, N297A Mutant | C020P.NA
Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C020P.LA
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only...
Palivizumab Biosimilar, N297A Mutant | C021P.NA
Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...